chr8-27634204-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_016240.3(SCARA3):āc.4A>Cā(p.Lys2Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000309 in 1,392,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_016240.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCARA3 | NM_016240.3 | c.4A>C | p.Lys2Gln | missense_variant | 1/6 | ENST00000301904.4 | NP_057324.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCARA3 | ENST00000301904.4 | c.4A>C | p.Lys2Gln | missense_variant | 1/6 | 1 | NM_016240.3 | ENSP00000301904.3 | ||
SCARA3 | ENST00000337221.8 | c.4A>C | p.Lys2Gln | missense_variant | 1/6 | 1 | ENSP00000337985.3 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152052Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000300 AC: 3AN: 100022Hom.: 0 AF XY: 0.0000345 AC XY: 2AN XY: 57952
GnomAD4 exome AF: 0.0000145 AC: 18AN: 1240262Hom.: 0 Cov.: 30 AF XY: 0.0000164 AC XY: 10AN XY: 608822
GnomAD4 genome AF: 0.000164 AC: 25AN: 152052Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | The c.4A>C (p.K2Q) alteration is located in exon 1 (coding exon 1) of the SCARA3 gene. This alteration results from a A to C substitution at nucleotide position 4, causing the lysine (K) at amino acid position 2 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at